Wesana Health Holdings Inc.
OTC: WSNAF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Daniel Carcillo
- Employees
- 7
- Headquarters
- Chicago, United States
- IPO year
- 2021
- Market cap
- $341.0K
- Website
- https://www.wesanahealth.com
Loading WSNAF…
Loading profile data…Frequently asked questions about WSNAF
What does Wesana Health Holdings Inc. (WSNAF) do?
Wesana Health Holdings Inc. is a life sciences firm dedicated to advancing and providing psychedelic-based therapies, including psilocybin-enhanced psychotherapy, primarily targeting the treatment of traumatic brain injuries (TBI). The company focuses on pioneering scientifically validated compounds and therapeutic strategies. Its mission is to...
Where does WSNAF trade?
Wesana Health Holdings Inc. (WSNAF) trades on the Other OTC.
What sector is WSNAF in?
Wesana Health Holdings Inc. (WSNAF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Wesana Health Holdings Inc.?
Daniel Carcillo is the chief executive officer of Wesana Health Holdings Inc. (WSNAF).
Where is Wesana Health Holdings Inc. headquartered?
Wesana Health Holdings Inc. is headquartered in United States.
Does WSNAF pay a dividend?
Wesana Health Holdings Inc. (WSNAF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WSNAF go public?
Wesana Health Holdings Inc. (WSNAF) completed its initial public offering in 2021.